drugset / Trial / NCT01074632
Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl
Summary
The objective of this study is to evaluate the effect of calorie and fat content on the pharmacokinetics of Lurasidone HCl in subjects with schizophrenia, schizoaffective disorder, or schizophreniform disorder.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lurasidone | Small molecule | 120 mg | — |